Evidence map›Paper›PMID 39238604›Full record

ArticlePNAS nexus2024

R2C2 + UMI: Combining concatemeric and unique molecular identifier-based consensus sequencing enables ultra-accurate sequencing of amplicons on Oxford Nanopore Technologies sequencers.

Dori Z Q Deng, Jack Verhage, Celine Neudorf, Russell Corbett-Detig, Honey Mekonen, Peter J Castaldi, Christopher Vollmers

Abstract read
In one paragraph

Article in PNAS nexus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A temporal and spatial atlas of adaptive immune responses in the lymph node following viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Dori Z Q DengDepartment of Molecular, Cellular, and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA 95064, USA.ORCID https://orcid.org/0000-0002-9320-9430
Jack VerhageDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Celine NeudorfDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Russell Corbett-DetigDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.ORCID https://orcid.org/0000-0001-6535-2478
Honey MekonenDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Peter J CastaldiChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Christopher VollmersDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA 95064, USA.ORCID https://orcid.org/0000-0002-7626-6222

Funding

Realizing the potential of long-read sequencing technologyR35GM133569 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Christopher Vollmers · 2019 to 2026
$3.4M
NIGMS NIH HHS R35 GM133569
6 · The paper itself

Abstract

The sequencing of PCR amplicons is a core application of high-throughput sequencing technology. Using unique molecular identifiers (UMIs), individual amplified molecules can be sequenced to very high accuracy on an Illumina sequencer. However, Illumina sequencers have limited read length and are therefore restricted to sequencing amplicons shorter than 600 bp unless using inefficient synthetic long-read approaches. Native long-read sequencers from Pacific Biosciences and Oxford Nanopore Technologies can, using consensus read approaches, match or exceed Illumina quality while achieving much longer read lengths. Using a circularization-based concatemeric consensus sequencing approach (R2C2) paired with UMIs (R2C2 + UMI), we show that we can sequence an ∼550-nt antibody heavy chain (Immunoglobulin heavy chain - IGH) and an ∼1,500-nt 16S amplicons at accuracies up to and exceeding Q50 (<1 error in 100,000 sequenced bases), which exceeds accuracies of UMI-supported Illumina-paired sequencing as well as synthetic long-read approaches.

Identifiers

PMID39238604
PMCPMC11376274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.